|Deltex Medical Group
||EPS - Basic
||Market Cap (m)
|Health Care Equipment & Services
Deltex Medical Share Discussion Threads
Showing 18601 to 18624 of 18625 messages
|Better one later ........................ if you like loss making small caps|
|Good chance to average down :-)|
|I have watched these for a very very long time, I currently own 400,000 at an average of 10p a share. Will I ever see a profit ?|
|But wait for it...........
Mind you if you buy you better be aware of the cash position.|
|Here comes a buying opportunity!|
|Hopefully not haemorrhaging !|
|I wonder how the cashflow is going?|
|Enigma machine? Nothing Florence Nightingale couldn't handle while doing the rounds in Scutari. In fact probably beneath her.|
|try Bletchley Park|
|Now where's my Enigma machine gone ?|
The last time you asked that question I put up a list of the months new accounts were announced. There never was a clear trend, and one is inclined to think that if there was any pattern, it could be modelled on the poisson distribution (think the periodicity of earthquakes). It can't, though, because the announcements are not entirely independent - for example, last month three new accounts were announced in one day. But overall, in any month, there is around a 60% chance of at least one new account being announced.
Here's the data again, plus the cumulative totals. It only comes to 21, not 27, because I started in January 2015. On the basis of the cumulative plot, you'd expect the target of 30 to be hit by the end of the year.
|Where are those US accounts ?|
|Or is it a comment on Deltex's UK sales team?|
|Reading both Deltex and Lidco reports, my guess is the latter is benefiting because it is present in post op, and easier to use regardless of whether the output has clinical value or not. As hospitals try to save and consolidate to one supplier, they are therefore opting for Lidco. Puts a lot of weight on the ease of use - so I hope the new truflow probes really are a step up. The evidence base has also supported ODM recently, but we know a lot of clinicians pay little attention to that. Since 2013 they've lost 60%+ of the probe business, I'm hoping a large proportion of what remains are die hard ODM users, and we can see some incremental progress from that base (but who knows).|
|I suspect given the size of the Deltex U.K. sales force there was little complacency about the effort required. Lidco more post op than intraoperative? Perhaps former less impacted by cuts. Dunno.|
|I would have thought it was quite simple. Lidco was always a better managed company than Deltex, even through their product was inferior. If you have an inferior product, you have to work harder to sell it, and I think Lidco knew this. Deltex were utterly complacent in the UK, believing that the NICE recommendation would sell their products for them. EP pretty much admitted as such in a recent interview, when he said that Deltex are going back to marketing to individual doctors. It's tempting to think that the real rot set in with Deltex when EP took over from Andy Hill, though on the other hand Deltex's US strategy seems to be working, and that is something that EP has spearheaded.|
|Even stranger given that NICE used ODM as the basis for recommending iofm, and trial using Lidco was a failure.|
|Lidco disposables double that of Deltex in U.K, and growing.It is strange that Lidco appear unaffected by the slump Deltex identify in the U.K iofm market.|
|Any guesses as to why Lidco's share price and Deltex's share price have gone up today?
I notice that Lidco, in its half-year report, says that it is the "clear market leader in the home market". Surely that wouldn't be a dig at anyone?|
|Well, if you saw the presidential debate last night, there's a reminder that one of the problems with the ACA (aka Obamacare) is that it is costing a fortune. It looks as if Hillary is going to win, and the ACA is going to remain in place. There is pressure on hospitals to reduce costs, and I believe that there are fines if they don't. So I would have said that a Democrat win would work in Deltex's favour.
There has been little or no discussion about Sterling on this board, which is surprising. I know EP seems dismissive of it, but given the falls in Sterling, I would have said they were important.
In terms of the European market, there is a big difference between GBPEUR at 1.40 and at 1.11. As Deltex don't have much in the way of costs in Euros, as far as I know, this means that the strong Euro must be having a significant impact on the bottom line, in terms of European sales.
Looking at the US, it is possible that the strong dollar is having a negative impact on Deltex, until they hit break even in this region. In other words, the extra cost of doing business in the US is not being full balanced by the increased Sterling value of sales. However maybe EP is right - the increased value of European sales is compensating for the US.
Another point to make is that Deltex, as a company, has a lower take-over price in Dollar terms than it had before Brexit, at it may now be a tempting target. I doubt the company could fend off a bid over 12p a share.|
yump, I concur with your wish that it be upside-down. Indeed, "were" instead of "was" would be correct.
J. K. Galbraith: "Financial forecasting exists only to make astrology look respectable."
J. K. Galbraith: "Predicting interest rates is the intellectual equivalent of cleaning toilets."|
|Well, something beginning with 'f' anyway ;-)|
You sound like Lord Sugar with that 'bleeding obvious', I take it buywell3 is fired!|